Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: An experimental In Vivo study

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Dall'Olmo, Luigi ^a   Fassan, Matteo ^b,c   Dassie, Elisa ^a,d   Scarpa, Marco ^a   Realdon, Stefano ^a,d   Cavallin, Francesco ^a   Cagol, Matteo ^a   Battaglia, Giorgio ^a   Pizzi, Marco ^c   Guzzardo, Vincenza ^c   Franceschinis, Erica ^c   Pasut, Gianfranco ^c   Rugge, Massimo ^a,c   Zaninotto, Giovanni ^e   Realdon, Nicola ^c   Castoro, Carlo ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY AND HOSPITAL TRUST OF VERONA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTROJEJUNOSTOMY; ESOPHAGUS CARCINOMA; ESOPHAGUS ULCER; EXPERIMENTAL STUDY; GASTROJEJUNOSTOMY; IN VIVO STUDY; INCIDENCE; MALE; METAPLASIA; MORTALITY; NONHUMAN; RAT; ANIMAL; CELL TRANSFORMATION; ESOPHAGUS TUMOR; PANCREAS; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; ESOPHAGEAL NEOPLASMS; MALE; PANCREAS; PROTON PUMP INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84912062655     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112862     Document Type: Article

References (32)

1. Shaheen NJ, Richter JE (2009) Barrett's oesophagus. Lancet. Mar 7; 373 (9666) : 850-61.
2. Rugge M, Pizzi M, Castoro C (2014) Definition of Barrett's Esophagus Dysplasia: Are We Speaking the Same Language? World J Surg. Jul 12. [Epub ahead of print].
3. Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, et al. (2013) Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013 Mar 15; 119 (6) : 1149-58.
4. Rugge M, Zaninotto G, Parente P, Zanatta L, Cavallin F, et al. (2013) Barrett's esophagus and adenocarcinoma risk: The experience of the North-Eastern Italian Registry (EBRA). Ann Surg. 2012 Nov; 256 (5) : 788-94; discussion 794-5.
5. Erratum in: Ann Surg. Mar; 257 (3) : 576. D'amore, Emanuele [corrected to d'Amore, Emanuele S G].
6. PT Chandrasoma, TR DeMeester (2006) GERD: Reflux to Esophageal Adenocarcinoma. Academic Press, Burlington, Massachusetts 01803, USA.
7. Wang JS, Varro A, Lightdale CJ, Lertkowit N, Slack KN, et al. (2010) Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus. Am J Gastroenterol. May; 105 (5) : 1039-45.
8. Haigh CR, Attwood SE, Thompson DG, Jankowski JA, Kirton CM, e al. (2003) Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor. Gastroenterology. 2003 Mar; 124 (3) : 615-25.
9. Green DA, Mlynarczyk CM, Vaccaro BJ, Capiak KM, Quante M, et al. (2011) Correlation between serum gastrin and cellular proliferation in Barrett's esophagus. Therap Adv Gastroenterol. Mar; 4 (2) : 89-94.
10. Moore KH, Barry P, Burn J, Falk G (2001) Adenocarcinoma of the rat esophagus in the presence of a proton pump inhibitor: A pilot study. Dis Esophagus. 14 (1) : 17-22.
11. Hao J, Zhang B, Liu B, Lee M, Hao X, et al. (2009) Effect of alpha-Tocopherol, N-Acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model. Int J Cancer. Mar 15; 124 (6) : 1270-5.
12. Miyashita T, Shah FA, Harmon JW, Marti GP, Matsui D, et al. (2013) Do proton pump inhibitors protect against cancer progression in GERD? Surg Today. 2013 Aug; 43 (8) : 831-7.
13. Erickson RA, Bezabah S, Jonas G, Lifrak E, Tarnawski AS (1991) Chronic omeprazole treatment increases duodenal susceptibility to ethanol injury in rats. Dig Dis Sci. Jul; 36 (7) : 897-904.
14. Miwa H, Oshima T, Sakurai J, Tomita T, Matsumoto T, et al. (2009) Experimental oesophagitis in the rat is associated with decreased voluntary movement. Neurogastroenterol Motil. 2009 Mar; 21 (3) : 296-303.
15. Yenişehirli A, Naseri E (2008) Omeprazole, lansoprazole and pantoprazole had no effect on blood pressure and electrocardiogram of anesthetized rat. Pharmacol Res. Jul; 58 (1) : 65-71.
16. Waldum HL, Brenna E, Martinsen TC (2000) Safety of proton pump inhibitors. Aliment Pharmacol Ther. Nov; 14 (11) : 1537-8.
17. Lloyd M, Wolfensohn S (1998) Practical use of distress scoring systems in the application of humane endpoints. In: Hendriksen CFM and Morton DB (eds.) Proceedings of the International Conference on Humane Endpoints in Animal Experimentation for Biomedical Research, 22-25 November 1998, Zeist, The Netherlands, 48-53. Royal Society of Medicine Press Limited, London, 1998.
18. Dedja A, Dall'Olmo L, Cadrobbi R, Baldan N, Fante F, et al. (2005) Heterotopic cardiac xenotransplantation in rodents: Report of a refined technique in a hamster-To-rat model. Microsurgery. 2005; 25 (3) : 227-34.
19. Ingravallo G, Dall'Olmo L, Segat D, Fassan M, Mescoli C, et al. (2009) CDX2 hox gene product in a rat model of esophageal cancer. J Exp Clin Cancer Res. Aug 7; 28: 108.
20. Su Y, Chen X, Klein M, Fang M, Wang S, et al. (2004) Phenotype of columnarlined esophagus in rats with esophagogastroduodenal anastomosis: Similarity to human Barrett's esophagus. Lab Invest. 2004 Jun; 84 (6) : 753-65.
21. Fein M, Peters JH, Chandrasoma P, Ireland AP, Oberg S, et al. (1998) Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg. May-Jun; 2 (3) : 260-8.
22. Buskens CJ, Hulscher JB, van Gulik TM, Ten Kate FJ, van Lanschot JJ (2006) Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus. J Surg Res. Oct; 135 (2) : 337-44.
23. Glickman JN, Chen YY, Wang HH, Antonioli DA, Odze RD (2001) Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus. Am J Surg Pathol. May; 25 (5) : 569-78.
24. Hagiwara T, Mukaisho K, Ling ZQ, Sugihara H, Hattori T (2007) Development of pancreatic acinar cell metaplasia after successful administration of omeprazole for 6 months in rats. Dig Dis Sci. May; 52 (5) : 1219-24.
25. Jolly AJ, Wild CP, Hardie LJ (2004) Acid and bile salts induce DNA damage in human oesophageal cell lines. Mutagenesis 19 (4) : 319-24.
26. Katzung BG, Masters S (2012) Basic and Clinical Pharmacology. 12th Edition. Lange Basic Science.
27. Fitzgerald RC, Omary MB, Triadafilopoulos G (1996) Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model. J Clin Invest. Nov 1; 98 (9) : 2120-8.
28. Clemons NJ, McColl KE, Fitzgerald RC (2007) Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms. Gastroenterology. Oct; 133 (4) : 1198-209.
29. Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G (1999) Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology. Aug; 117 (2) : 327-35.
30. Feagins LA, Zhang HY, Hormi-Carver K, Quinones MH, Thomas D, et al. (2007) Acid has antiproliferative effects in nonneoplastic Barrett's epithelial cells. Am J Gastroenterol. Jan; 102 (1) : 10-20.
31. Wetscher GJ, Hinder RA, Smyrk T, Perdikis G, Adrian TE, et al. (1999) Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux. Dig Dis Sci. Jun; 44 (6) : 1132-5.
32. Viste A, Ovrebø K, Maartmann-Moe H, Waldum H (2004) Lansoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux. Gastric Cancer. 7 (1) : 31-5.